Loretta J. Nastoupil, MD, MD Anderson Cancer Center

Articles

Latest in Myeloma, Prostate Cancer, and Lymphoma From ASCO 2021: Drs Neal Shore, Loretta Nastoupil, and Sandy Wong

June 9th 2021

OncLive sits down with Sandy Wong, MD; Neal Shore, MD; and Loretta Nastoupil, MD, to share the the insight on data in multiple myeloma, prostate cancer, and non-Hodgkin lymphoma at the 2021 ASCO Annual Meeting.

Evolving Therapies in R/R DLBCL: Concluding Remarks

March 26th 2021

R/R DLBCL: A Glance at Using Novel Therapies Moving Forward

March 26th 2021

R/R DLBCL: Novel Therapies in the Pipeline

March 26th 2021

Treating Primary Refractory DLBCL

March 19th 2021

Bridging Therapy in R/R DLBCL

March 19th 2021

R/R DLBCL: Transplants in the Era of CAR-T

March 12th 2021

CAR T for R/R DLBCL: Improving Access and Utilization

March 12th 2021

CAR T for R/R DLBCL: Safety/Tolerability

March 5th 2021

Understanding the CAR-T Process: Collection Through Infusion

March 5th 2021

Treating R/R DLBCL With CAR-T: Current Barriers

February 26th 2021

CAR-T Treatment Options for R/R DLBCL

February 26th 2021

CAR T-Cell Therapy for R/R DLBCL

February 19th 2021

Novel Therapies for R/R DLBCL

February 19th 2021

R/R DLBCL: Treating With Tafasitamab-Lenalidomide

February 12th 2021

Tafasitamab Combined With Lenalidomide in R/R DLBCL

February 12th 2021

R/R DLBCL: Second-Line Treatment Options

February 5th 2021

DLBCL: Treating Patients Following Relapse on Frontline Therapy

February 5th 2021

DLBCL: Treatment Considerations for Challenging Populations

January 29th 2021

DLBCL: Circumstances for Deviating Away From R-CHOP

January 29th 2021